Valent BioSciences Announces U.S. EPA Registration of AccedeTM Plant Growth Regulator for Effective Thinning of Stone Fruit and Apples

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., June 30, 2021 – Valent BioSciences LLC announces U.S. EPA (Environmental Protection Agency) registration of a new plant growth regulator (PGR), which will be marketed under the brand name AccedeTM, utilizing the active ingredient 1-aminocyclopropane-1-carboxylic acid (ACC).

Accede is the first PGR based on a naturally occurring compound developed specifically for thinning of stone fruit, including peaches and nectarines. It also gives apple growers an effective tool to thin apples in the late thinning window when fruit are 15-20 mm in diameter. Until now, no fruit thinner has provided reliable thinning at this stage of development. Use of Accede will reduce the need for costly hand thinning to adjust the crop load and generate higher fruit quality and grower returns.

ACC occurs naturally in plants. Once applied to the crop, the active ingredient in Accede is quickly converted to ethylene using the plant’s natural biochemical pathways. The ethylene generated after application of Accede stimulates and accelerates flower and fruit drop in apples and stone fruit.

Accede does not leave ACC residues at harvest, as it is rapidly broken down in plants. The product was classified as a biochemical by the EPA in 2015. The technology in Accede is covered by numerous patents.

“This game-changing plant growth regulator will revolutionize the way tree fruit growers manage their crop loads,” said Dr. Warren Shafer, Vice President of Global Research and Development and Regulatory Affairs at Valent BioSciences. “Its registration in the U.S. is the culmination of more than a decade of research and development collaboration between Valent BioSciences, Valent U.S.A. LLC and our parent company, Sumitomo Chemical Co., Ltd. We are proud to bring this unique, effective biorational product to market and help growers realize its tremendous benefits.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences and Valent U.S.A. Collaborate with Halo on Open Innovation Initiative Seeking New Technologies and Solutions

FOR IMMEDIATE RELEASE

SAN RAMON, Calif., June 23, 2021 – Valent BioSciences  and Valent U.S.A. are collaborating with Halo to launch an open innovation initiative utilizing Halo’s state-of-the-art technology platform. This platform connects enterprises with universities, researchers and start-ups around the world to effectively crowd-source innovative ideas, technologies and solutions with experts who are working on either solving the same problems or similar problems across a range of scientific endeavors that could be applied elsewhere.

Utilizing Halo, sponsors post areas of interest for research collaborations through requests for proposals (RFPs), and scientists respond with simple, standardized proposals. Organizations then review the proposals and reach out directly to learn more or provide feedback. If the parties are interested in sharing confidential information or negotiating an agreement, the conversation moves off of Halo and the process proceeds as usual with any industry collaboration.

“Halo is a marketplace and network that drives science forward by connecting scientists directly with leading companies to promote research collaborations and funding opportunities,” said Kevin Leland, CEO and founder of Halo. “We’re thrilled to partner with industry leaders Valent BioSciences and Valent U.S.A. so that researchers who share their dedication to agricultural sustainability can benefit from their expertise and resources.”

In its first venture with Halo, Valent BioSciences and Valent U.S.A. are focused on finding partners to further their research in three specific areas. These areas include soil carbon sequestration, the ecosystem services benefits of mycorrhizal fungi colonization and novel compounds that can bolster crop protection and enhancement portfolios. The three RFPs are posted on the Halo website for interested parties to learn more about the various opportunities.

In addition, Valent BioSciences and Valent U.S.A. are hosting several webinars on June 29 that will provide additional details about the companies and RFPs. Participants can register for these webinars on the Halo website.

“We are excited to collaborate with Halo in tackling some of our planet’s most urgent challenges in accordance with our commitment to the UN Sustainable Development Goals (SDGs),” said Dr. Warren Shafer, Vice President, Global R&D and Regulatory Affairs, Valent BioSciences. “With an opportunity to shape the future, we look to reach beyond our corporate boundaries to engage with like-minded collaborators and innovative technologies that can be tailored into sustainable and leading-edge solutions that will help our growers and the planet thrive. We believe that through our partnership with Halo, Valent Biosciences and Valent U.S.A. can broaden our connection to the global scientific and business communities, while communicating our commitment to people, planet and productivity.”

 About Halo

Halo is a partnering platform where companies and scientists join forces to bring new innovations to market. Through a simple, streamlined RFP process, companies can quickly review proposals with their team, learn about new technologies and cultivate relationships with the scientists behind them. For more passive scouting and brand building, companies can highlight existing research partnerships and technology interests on their innovation page. Since launching in January 2020, Ph.D. scientists and startups across 65 countries and six continents have submitted more than 1,000 proposals on Halo. To learn more, visit halo.science/sponsors.

 About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Valent U.S.A. LLC

Valent U.S.A., headquartered in San Ramon, California, develops and markets products in the United States, Canada and Mexico that advance sustainable agriculture, protect crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and biorational products developed by its affiliate, Valent BioSciences LLC. For additional information, visit the company’s website at: https://www.valent.com

About Sumitomo Chemical Co., Ltd.
Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies. It offers a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated sales revenue for fiscal year 2020 was JPY 2.287 trillion and the number of employees is about 34,000 as of March 31, 2020. For additional information, visit the company’s website at https://www.sumitomo-chem.co.jp/english/.

For more information, contact:

Steve Tatum
(925) 951-3164
Email: steve.tatum@valent.com

or

John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Introduces MetaLarv® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., May 5, 2021 – Valent BioSciences, the global leader in biorational solutions for Public Health and Integrated Vector Management programs, has introduced MetaLarv® XRP, an innovative new formulation designed specifically for extended residual control of mosquito larvae in catch basins and storm drains.

Leveraging MetaLarv’s proven Triple Release Technology™ for residual control, the new XRP (extended release pouch) formulation is designed to provide mosquito abatement professionals more reliable and consistent control of West Nile virus vectors in catch basins by pairing the flexibility of a water soluble pouch with the residual control (90-100 days) of a briquet.

“We’ve learned from our customers and the literature that the active ingredient release profile and duration of traditional long-lasting catch basin treatment options can be challenging,” said Banugopan Kesavaraju, Global Technical Manager for Valent BioSciences’ Public Health and Forest Health Business Units. “We developed MetaLarv XRP to help mosquito abatement professionals overcome these challenges by combining the flexibility and immediacy of a pouch with the long residual of an extended release briquet.”

Catch basins and storm drains are prime mosquito breeding grounds for West Nile virus vectors and can be difficult for technicians to access with certain types of products. Water soluble pouch (WSP) formulations are malleable to fit through the narrow grates that often cover these closed habitats, and release effective active ingredient immediately. The concern is that they typically provide control for only 1-2 months. For mosquito control programs that require control over a longer duration, this means more applications per season – a significant challenge in areas with hundreds or even thousands of such drains and basins.

To get a longer residual (90-120 days), many districts opt for mosquito larvicide extended release (XR) briquets, which can be dropped through grates that have openings wide enough to receive them. However, the physics of this “brick plunge” can drive briquets downward to become embedded in sludge or other debris. Such lodging reduces the amount of XR briquet surface area that comes in contact with the water column, meaning slower and diminished release of active ingredient. Water temperature also plays a role in the release profile of briquets, which lags in colder temperatures early in the season. These drawbacks often translate into inconsistent results.

MetaLarv was first introduced in 2012 as a highly functional spherical pellet (S-PT) formulation of the insect growth regulator (S)-methoprene, which disrupts insect growth and prevents the emergence of adult mosquitoes that are capable of transmitting harmful diseases such as West Nile virus, malaria, dengue fever, and encephalitis. MetaLarv S-PT provided mosquito control districts with significant operational advantages in the control of floodwater mosquitoes. Like its successor, MetaLarv S-PT combined the best features from two different formulation types; it provided the low-rate application flexibility of a granule combined with the residual control of dynamic floodwater habitats of a pellet formulation.

MetaLarv XRP now delivers Valent BioSciences’ proprietary Triple Release Technology benefits into the challenging environments of storm drains and catch basins.

When applied, MetaLarv XRP floats briefly on the water’s surface where it quickly dissolves to deposit the full volume of its Triple Release “micro briquets” into the mosquito habitat. The first release occurs immediately with a flash of active ingredient to control initial mosquito broods and is not dependent on water temperature. The second release occurs over time as a further portion of the micro briquets breaks down in standing water, allowing for control of multiple mosquito broods during a flood. The third release allows for product to withstand dry-down/reflood situations in catch basins, ensuring MetaLarv XRP is ready for the next flooding cycle. This “trifecta” approach ensures multiple point source coverage for consistent control over an extended period of time.

“We work in an industry where resources are limited and the stakes for success or failure are high,” said Kesavaraju. “When our customers make an application, they need to be able to walk away with the confidence that the resources they’ve expended are going to provide the level of control they expect. MetaLarv XRP is another example of our ongoing commitment to provide specialized solutions –based on specific mosquito larval habitats – that help public health professionals reduce the risk of vector-borne disease.”

MetaLarv XRP joins MetaLarv S-PT and the Valent BioSciences biorational mosquito larvicides, VectoBac®, VectoPrime®, VectoMax®, VectoLex®, and Bactimos®, to provide the public health industry’s most comprehensive range of target-specific, biorational larvicides for mosquito abatement professionals and health care officials around the globe.

For more information, visit www.valentbiosciences.com/publichealth or contact a Valent BioSciences technical sales representative.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Celebrates 50th Anniversary of DiPel® Biological Insecticide as the Industry’s Most Effective Lepidopteran Control Product

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., March 5, 2021 – Only a few crop protection products have stood the test of time as increasing regulations, resistant pests, and grower preferences have changed over the years. Yet DiPel® Biological Insecticide stands alone as the leading lepidopteran biological control product growers have depended upon for 50 years. To underscore this important milestone, Valent BioSciences is announcing a variety of anniversary activities intended to celebrate the benefits of DiPel and commemorate its contributions as a pioneer in sustainable global agriculture.

First registered in the United States by the U.S. Environmental Protection Agency (EPA) in 1971, DiPel contains the naturally occurring microorganism Bacillus thuringiensis subspecies kurstaki (Btk) strain ABTS 351. Because DiPel is made from the Btk strain ABTS 351, Valent BioSciences is celebrating the 50thanniversary on March 5 (or, 3/5) at 1 p.m. Central Time (CT) and will recognize the date hereafter as “DiPel Day.”

Active on a broad spectrum of lepidoptera larvae, DiPel provides high-quality, effective, and economical insect pest control on more than 200 crops in more than 60 countries. These crops include vegetables, fruits, nuts, vines, cotton, oil palm, soybean, corn, and many others. The product is also labeled in many countries for use on turf, ornamentals (greenhouse, field, and landscape), and retail garden and landscape applications. DiPel is not harmful to humans, wildlife, or the environment, and is non-toxic to pollinators and other beneficial insects.

The product stops damage from caterpillars very quickly; while the pest appears alive and active, the larvae will stop feeding within one hour of ingesting DiPel. Its Cry protein profile provides numerous modes of action in the caterpillar gut, making it an effective integrated pest management tool for preventing insect resistance to other insecticides.

To commemorate DiPel’s 50th anniversary, Valent BioSciences has created a variety of materials. Chief among them is the theme “Forward Thinking Crop Protection™,” which communicates DiPel’s relevance yesterday, today, and into the future. This theme is incorporated in a distinctive new logo combining the theme, DiPel logo, and “50 years.” Because the DiPel trade name is based upon the “lepid” portion of lepidoptera (the targeted insect class) spelled backwards, the company introduced a brief animated graphic emphasizing the name’s origin.

Special 50th anniversary product packaging featuring a scannable QR code linking customers to a website landing page is also being developed and rolled out this year.

The new landing page is devoted to DiPel’s anniversary and its success. It includes video testimonials from DiPel users, a photo gallery of the product in use around the world, a downloadable PDF highlighting 50 facts about DiPel, and photos and videos showcasing how the product works and is produced.

“DiPel’s 50th anniversary provides an outstanding opportunity to celebrate the brand’s heritage of innovation, reliability, and performance, while also thanking our customers around the globe for their ongoing support,” said Rosa Gimenez, Valent BioSciences’ Global Business Director, Biorational Crop Protection. “While we are proud of the brand’s achievements, we continue to innovate and perfect the product, and believe that the best is yet to come.”

Click here to learn more about DiPel and the 50th anniversary celebration.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Announces New Educational Initiatives Supporting World Soil Day, Healthy Soils, and Sustainable Crop Production

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., December 3, 2020 – In support of World Soil Day, Valent BioSciences LLC, theworldwide leader in the development, manufacturing, and commercialization of biorational products,announced several strategic initiatives that highlight the importance of healthy soils and sustainable crop production. World Soil Day is a United Nations International Day of Significance that is held annually on December 5th in order to emphasize the role of healthy soil and advocate for the sustainable management of soil resources.

“Soil health is the new frontier in agriculture, and the future of sustainable crop production truly depends upon the living ecosystem underground,” said Steve Wiest, Valent BioSciences’ Global Business Director, Biorational Rhizosphere. “Valent BioSciences is deeply committed to leaving a legacy of healthy soils for future generations through our investments in soil health research, education, and novel inoculant products that help growers easily integrate innovative biological seed and soil technologies into their existing crop management practices. As a global leader in agriculture, we pledge our support for World Soil Day by expanding awareness to everyone dependent upon healthy soils for life.”

With increasing concern about the impact of a growing population on land, water, and environmental resources, Valent BioSciences has produced a new video entitled Soils for Life that showcases how healthy, living soils can help restore agricultural and environmental balance. It stresses how sustainable farming techniques, including soil inoculants, can produce healthier plants that absorb more carbon from the air and hold it underground to rejuvenate degraded soil and boost food production. The video interviews several technical experts and a grower who has successfully pioneered and implemented a variety of effective soil management practices to improve his bottom line and the environment.

Click here to watch Soils for Life.

In 2021, Valent BioSciences will also launch an educational podcast series called Sustaining Soils. These quarterly external podcasts will feature industry pioneers in soil health, academic and research leaders, members of the company’s Soil Health Advisory Board, and other technical experts. The podcasts will explore such subjects as:

  • The role of functional soil microorganisms in agriculture
  • Mycorrhizal fungi inoculants that improve soil health and crop production
  • The science of non-destructive rhizosphere imaging

To further define and shape the science of soil health, Valent BioSciences maintains an ongoing collaboration with the renowned Donald Danforth Plant Science Center in St. Louis, Missouri. Scientists at the Danforth Center use state-of-the-art imaging equipment and algorithms to pioneer new techniques that evolve the way we observe interactions between plant roots and beneficial soil microorganisms within the rhizosphere.

Valent BioSciences employees are also encouraged to engage in hands-on, soil-related activities through a variety of volunteer initiatives. One example is the company’s relationship with the local Lake County Forest Preserves, which gives employees an opportunity to participate firsthand in seed harvesting, soil cultivation, and other activities. The company is seeking to expand this partnership next year to further study the role of soil microorganisms within natural, Midwest ecosystems.

Finally, Valent BioSciences and its parent company, Sumitomo Chemical Co., Ltd., are committed to the United Nations’ Sustainable Development Goals, which include tackling climate change. In fact, Valent BioSciences technologies directly impact nearly half of these 17 audacious goals.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Boosts Capabilities with New Biorational Research Unit at Sumitomo Chemical Health & Crop Sciences Research Laboratory

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., November 19, 2020 – Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, is expanding its research collaboration with parent company Sumitomo Chemical Co., Ltd. by establishing a dedicated Biorational Research Unit at Sumitomo Chemical’s Health & Crop Sciences Research Laboratory (HCRL) in Takarazuka, Hyogo, Japan. Both organizations have worked closely together on specific projects at the HCRL for several years in response to the growing importance of biorational and sustainable agricultural solutions. The enhanced partnership, which includes the addition of technical staff with expertise in a broad variety of areas, begins on December 1.

“This deeper collaboration is a natural evolution of our ongoing relationship with the HCRL, and will enable us to broaden our biorational research programs and activities in a dedicated and more structured manner,” said Ted Melnik, Valent BioSciences’ Executive Vice President and Chief Operating Officer. “It also kicks off some of the critical initiatives announced recently as part of our SynBio (synthetic biology) initiative at the Biorational Research Center in Libertyville that will help accelerate our work in creating next-generation businesses in this burgeoning field.”

One of the primary benefits to Valent BioSciences of closer collaboration with the HCRL includes greater access to its various research platforms and leading-edge technologies that can grow the biorational business significantly, both in Japan and globally.

Initially, the Biorational Research Unit at the HCRL will focus on biopesticide discovery, field application of plant growth regulators (PGRs) in Japan, and various projects related to arbuscular mycorrhizal fungi (AMF). As the group’s technical capabilities and expertise increase, Valent BioSciences will continue expanding its range of research activities.

“Because the HCRL is a centralized research facility, we will be able to leverage its in-house expertise and facilities on an ongoing basis and augment our research requirements as needed,” said Melnik. “We will also receive greater technical support for our business in Japan while benefiting from the broader scientific opportunities that can be achieved by networking with Japanese academia.”

The HCRL was established about 50 years ago to help create healthier and more hygienic lives, and contribute to improving the yield of food crops and agricultural productivity through its expertise in organic synthetic chemistry, biology, and formulation technologies. The laboratory is engaged in the development of new agricultural chemicals and functional fertilizers, more effective and safer household insecticides, and technologies for preventing infectious diseases, as well as efficient synthetic methods for pharmaceutical chemicals. It collaborates with Sumitomo Chemical’s overseas Group companies to incorporate the needs of global customers into its research and development activities, thereby contributing to the expansion and globalization of the company’s business.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

SATT Paris-Saclay and Valent BioSciences Sign Joint Agreement to Develop Breakthrough Sustainable Biopesticide Technologies

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., October 27, 2020 – In a first of its kind international partnership, SATT Paris-Saclay, the Technology Transfer Accelerator Office of one of the world’s leading innovation clusters, and Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, signed a joint agreement to develop breakthrough sustainable biopesticide technologies for agricultural applications.

Utilizing a strategic process, the organizations will focus on introducing emerging technologies and products that are environmentally friendly, effective, and commercially viable.

SATT Paris-Saclay is working in partnership with Micalis unit (part of INRAE: France National Research Institute for Agriculture, Food, and Environment), one of the most important microbiology laboratories in the Paris region. By collaborating with leading technology companies, SATT Paris-Saclay intends to bring new innovations to the marketplace. Valent BioSciences offers deep experience, state-of-the-art manufacturing capabilities, a global distribution network, and a longstanding track record of developing innovative technologies.

“For its first international collaboration, SATT Paris-Saclay very much looks forward to this partnership with the premier biocontrols company,” said Xavier Apolinarski, Chairman of SATT Paris-Saclay. “Valent BioSciences shares our vision of supporting sustainable practices for food production now and in the future. The company’s expertise, broad technical resources, and commitment to innovation and excellence will help us develop highly beneficial products that provide maximum impact.”

“We continue to invest in promising new technologies that will change the game in sustainable agriculture,” said Regina Rieckenberg, Vice President of Global Marketing and Business Management for Valent BioSciences. “Demand for  sustainable products continues to grow and our partnerships with leading transfer organizations such as SATT Paris-Saclay help us create unique new products that bring value to customers.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About SATT Paris-Saclay

From innovating concepts to practical applications, SATT Paris-Saclay (Technology Transfer Accelerator Office) invests in disrupting technologies coming out of its territory’s research labs to accelerate their level of technological maturity and secure their entry into the markets. As a TTO for Université Paris-Saclay and Institut Polytechnique de Paris, SATT generates business competitivity and creates a strong dynamic around deeptech innovations, boosting competitivity. SATT’s experts support researchers before project funding, to define the most appropriate industrial transfer strategy. Most demanded services include market opportunity study or IP portfolio analysis. SATT offers services dedicated to further industrial strategies of open-innovation and technological scouting. It also addresses companies who wish to exploit an innovation already funded by SATT or engage in specific developments with a lab supported by funds from SATT. For more information, visit the organization’s website at  www.satt-paris-saclay.fr/en/home.

About INRAE

INRAE is France’s new National Research Institute for Agriculture, Food and Environment, created on January 1, 2020, It was formed by the merger of INRA, the National Institute for Agricultural Research, and IRSTEA, the National Research Institute of Science and Technology for the Environment and Agriculture. As the world’s top institute for research on agriculture, food, and the environment, INRAE will help address these concerns. It will use research, innovation, and support for public policies as tools to guide the emergence of sustainable agricultural and food production systems. The institute aims to carry out science dedicated to life, humans, and the Earth that uncovers solutions to our most pressing concerns. For more information, visit the organization’s website at https://www.inrae.fr/en.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728
Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Announces Creation of New Chief Commercial Officer Position and Other Organizational and Reporting Changes to Drive Growth

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., September 23, 2020 – To help drive continued acceleration and growth, Valent BioSciences LLC, the worldwide leader in the development, manufacturing, and commercialization of biorational products, announced the creation of a new Chief Commercial Officer position, as well as other key organizational and reporting changes within the business. All of the changes are effective October 1.

Salman Mir, Executive Vice President and Chief Operating Officer of Pace International LLC and Mycorrhizal Applications LLC, both subsidiaries of Valent BioSciences, is named Chief Commercial Officer of Valent BioSciences and is being promoted to President of Pace International. He returns to Valent BioSciences, where he served as Vice President of Global Marketing and Business Management earlier in his career. Mir was also Head of AgroSolutions Division International (Asia Pacific) and General Manager Sumitomo Chemical Asia (SCA). He will report to Ted Melnik, Valent BioSciences’ Executive Vice President and Chief Operating Officer.

In his new role, Mir will strengthen the company’s overall commercial organization and elevate the development and execution of its global Sustainable Solutions platform in partnership with Valent U.S.A. and Sumitomo Chemical Co., Ltd. affiliates around the world to generate increased global growth. Mir will relocate to Valent BioSciences’ global Biorational Headquarters in Libertyville from Pace International’s headquarters in Wapato, Washington.

Melnik will continue leading Valent BioSciences, but will now report to Nobuaki Mito, Managing Executive Officer, Health and Crop Sciences Sector, at parent company Sumitomo Chemical Co. Mir’s appointment as Chief Commercial Officer of Valent BioSciences will enable Melnik to devote additional attention to other critical business priorities and initiatives.

In addition, Rodrigo Cifuentes is being appointed Executive Vice President and Chief Operating Officer of Pace International, reporting to Mir. A replacement for Cifuentes’ current position as Vice President of Global Marketing and Business Development will be named at a later date.

Valent BioSciences’ Public Health and Forest Health businesses based in Libertyville will now report to Mir, while the Mycorrhizal Applications business, headquartered in Grants Pass, Oregon, will continue to report to him.

“This is an exciting time for our business, as the need for innovative biorational technologies and products has never been greater,” said Melnik. “These changes will strengthen our organization and position us for continued success as an industry leader in sustainable agriculture. I congratulate Salman and Rodrigo on their new assignments, which will help us continue to fulfill our commitment to creating value for our customers around the world in a sustainable manner.”

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728

Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences Moves into New Global Biorational Headquarters

FOR IMMEDIATE RELEASE

Biological Products Leader Relocates Headquarters to Join Biorational Research Center at Libertyville’s Innovation Park

LIBERTYVILLE, Ill., September 17, 2020 – Valent BioSciences LLC officially moved its global Biorational Headquarters (BHQ) to Innovation Park in Libertyville, Ill. The new headquarters is situated in the same complex as the more than 90,000-square-foot Biorational Research Center (BRC), which relocated from Long Grove, Ill., in 2018.

Previously located at 870 Technology Way in Libertyville, the Biorational Headquarters now shares the same address (1910 Innovation Way, Suite 100) as the BRC.

With its design carefully fine-tuned for the challenges of working in today’s COVID-19 environment, the new workspace features a specialized airflow filter system, Indigo-Clean LED lights that inhibit microbial growth, as well as sanitizing stations located throughout the office. The environmentally friendly facility also incorporates the latest energy-efficient technologies and safety features, reflecting the company’s commitment to promoting a safe and healthy work environment. In addition, the floorplan provides increased conference, project, and huddle rooms.

Employees at both the BHQ and BRC are currently in the pilot phase of wearing proximity contact tracing tags that alert the wearer when they are within six feet of another tag to help minimize exposure and create traceable employee contact logs.

“While the pandemic caused us to pivot when designing the space, we are excited to embrace our reimagined workspace in this attractive new facility,” said Ted Melnik, Executive Vice President and Chief Operating Officer of Valent BioSciences. “Having our state-of-the-art headquarters under the same roof as our research center is invaluable, and we are already seeing enhanced collaboration between functional business groups. We went from being a 20-minute drive apart at Long Grove to being within walking distance when we moved into the BRC, and now we’re right upstairs – the shared space provides a tremendous advantage.”

The new offices will enable Valent BioSciences to retain its position as the worldwide leader in the development, commercialization, and manufacturing of biorational products, keeping the company on the leading edge of global sustainability efforts in agriculture, public health, and forest health.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
John Mandel
Valent BioSciences
847-968-4728

Email: john.mandel@valentbiosciences.com

Download News Release

Valent BioSciences, ADAPCO Form Strategic Partnership in Public Health

FOR IMMEDIATE RELEASE

Relationship includes an exclusive distribution agreement for US markets

Libertyville, IL, August 29, 2018 — Valent BioSciences (VBC), the global leader in biorational solutions for public health, forest health, and agriculture, announced it has entered into a strategic partnership with ADAPCO, the world’s largest distributor of products to the professional mosquito control industry. As part of the agreement, ADAPCO will become the exclusive distributor of VBC’s broad range of biological-based mosquito control technologies in the US, Puerto Rico, and the Cayman Islands.

The move aligns two of Public Health’s most respected companies in an effort to better serve vector management programs across the US and Caribbean.

“This partnership creates an exciting future for VBC’s Public Health business, its customers, and the people we protect,” said Steve Krause, Global Business Director for VBC’s Public Health and Forestry businesses. “We operate in a highly technical industry, and ADAPCO’s proven history of excellence in the design and operation of equipment, field support, customer service, and the handling of our solutions made it a clear choice going forward.”

Krause indicates the partnership blossomed through ADAPCO’s work with VBC’s award winning technology across five Western states. VBC won a 2017 Chicago Innovation Award for its Wide Area Larvicide Spray (WALS™) application technology. Developed through more than 20 years of global research, WALS leverages VectoBac®, VBC’s advanced Bacillus thuringiensisspp. israelensisStrain AM65-52 (Bti) technology using a breakthrough method for delivering biorational larvicides into the hard-to-reach areas where Dengue- and Zika-transmitting mosquitoes breed.

“We are excited to foster a new era of vector control and mosquito suppression,” said Steve Burt, Managing Director, Specialty Ag/Hort, Azelis Americas. “This alignment of industry-leading teams – Valent Biosciences’ leadership in the space of biorational larvicides, together with ADAPCO’s field and application expertise – will usher in a transformational future for vector control in these regions.”

The effective date for the distribution agreement is October 1, 2018.

# # #

About Valent BioSciences

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorationalproducts with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About ADAPCO

Headquartered in Sanford, FL, ADAPCO is an Azelis Americas company. ADAPCO© is the world’s largest distributor of innovative insecticide products, technology, and equipment to the professional mosquito control industry. Azelis is a leading global specialty chemicals distributor, providing a diverse range of products and innovative services to more than 40,000 customers. ADAPCO operates with maximum regard for the user, consumer, and the environment to protect human health. For additional information, visit the company’s website at www.myadapco.com.

Media Contacts:

Rick Melnick
Valent BioSciences
847-968-4750

Email: rick.melnick@valentbiosciences.com

Terry Mullin
ADAPCO
203-883-1477

E-Mail: terry.mullin@azelisamericas.com

Download News Release